<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vedomostiregmed</journal-id><journal-title-group><journal-title xml:lang="ru">Регуляторные исследования и экспертиза лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Regulatory Research and Medicine Evaluation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3034-3062</issn><issn pub-type="epub">3034-3453</issn><publisher><publisher-name>Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30895/1991-2919-2023-13-3-473-480</article-id><article-id custom-type="elpub" pub-id-type="custom">vedomostiregmed-551</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Экспертное мнение</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EXPERT OPINION</subject></subj-group></article-categories><title-group><article-title>Рекомендации по оформлению раздела нормативной документации на лекарственные средства: родственные примеси (для метода ВЭЖХ)</article-title><trans-title-group xml:lang="en"><trans-title>Recommendations for the Contents of a Product Specification File: Related Substances (HPLC)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-4443-5441</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ваганова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vaganova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ваганова Ольга Александровна, канд. фарм. наук</p><p>Петровский б-р, д. 8, стр. 2, Москва, 127051</p></bio><bio xml:lang="en"><p>Olga A. Vaganova, Cand. Sci. (Pharm.)</p><p>8/2 Petrovsky Blvd, Moscow 127051</p></bio><email xlink:type="simple">vaganova@expmed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5904-8357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Натыкан</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Natykan</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Натыкан Алексей Андреевич, канд. хим. наук</p><p>Петровский б-р, д. 8, стр. 2, Москва, 127051</p></bio><bio xml:lang="en"><p>Alexey A. Natykan, Cand. Sci. (Chem.)</p><p>8/2 Petrovsky Blvd, Moscow 127051</p></bio><email xlink:type="simple">natykanaa@expmed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Научный центр экспертизы средств медицинского применения» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Centre for Expert Evaluation of Medicinal Products</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2023</year></pub-date><volume>13</volume><issue>3</issue><fpage>473</fpage><lpage>480</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ваганова О.А., Натыкан А.А., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Ваганова О.А., Натыкан А.А.</copyright-holder><copyright-holder xml:lang="en">Vaganova O.A., Natykan A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vedomostincesmp.ru/jour/article/view/551">https://www.vedomostincesmp.ru/jour/article/view/551</self-uri><abstract><p>Предложены рекомендации изложения в нормативной документации методики оценки качества лекарственных средств по показателю «Родственные примеси» при использовании метода ВЭЖХ. Рассмотрены особенности и предложена типовая схема редакционного оформления раздела «Родственные примеси». Унификация изложения и оформления текста нормативной документации позволит безошибочно выполнять испытание, получать достоверный результат и упростит экспертизу лекарственных средств.</p></abstract><trans-abstract xml:lang="en"><p>This article provides recommendations for documenting an analytical procedure for the determination of related substances by high-performance liquid chromatography in a product specification file (PSF). The article contains a description of specific aspects and a template for the typical contents and layout of the PSF section dedicated to related substances. A unified approach to the PSF content and layout will ensure error-free testing, reliable results, and streamlined regulatory assessments.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>родственные примеси</kwd><kwd>качество лекарственных средств</kwd><kwd>нормативный документ</kwd><kwd>высокоэффективная жидкостная хроматография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>related substances</kwd><kwd>quality of medicinal products</kwd><kwd>product specification file</kwd><kwd>HPLC</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
